{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:58:29Z","timestamp":1740135509730,"version":"3.37.3"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Transurethral resection of the prostate (TURP) is the first choice for the treatment of benign prostatic hyperplasia. However, Transurethral split of prostate (TUSP) also seems to have clear clinical efficacy and clinical promotion value. To better clarify the potential and limitations of this treatment of prostate hyperplasia. This study objectively evaluated the clinical efficacy and safety of TUSP.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The Pubmed, Cochrane Library, Embase, China National Knowledge Infrastructure (CNKI), Database for Chinese Technical Periodicals (VIP), Wanfang (Wanfang data), and SinoMed databases were searched for relevant studies. We then used Revman Manager 5.3 to perform a meta-analysis of all randomized controlled trials that evaluated the efficacy and safety of TUSP versus the classic surgical procedures commonly used in the clinic.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 7 studies involving 592 patients were included. The combined data showed that TUSP can shorten the operation time [MD: -33.68; 95% CI: \u2212\u200938.45 to \u2212\u200928.91; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001], reduce intraoperative blood loss [MD: -56.06; 95% CI: \u2212\u200962.68 to \u2212\u200949.43; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001], shorten the time of indwelling catheter [MD: -1.83; 95% CI: \u2212\u20091.99 to \u2212\u20091.67; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001], shorten the postoperative hospital stay length [MD: -1.61; 95% CI: \u2212\u20091.90 to \u2212\u20091.32; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001] and improved postoperative quality of life score (QOL) [MD: 0.16; 95% CI: 0.02 to 0.29; <jats:italic>P<\/jats:italic>\u2009=\u20090.02] compared to traditional surgical approaches. There were no statistically significant differences in international prostate symptom score (IPSS), maximum urinary flow rate (Qmax), residual urine volume (RUV), or complications between TUSP and traditional approached.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>TUSP can be an effective alternative for clinical treatment of benign prostatic hyperplasia. Given the limitations of the included studies, more high-quality randomized controlled trials are needed in the future to validate or update the results of this analysis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12894-020-00704-4","type":"journal-article","created":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T05:03:57Z","timestamp":1599109437000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy and safety of transurethral split of prostate for benign prostatic hyperplasia: a meta-analysis"],"prefix":"10.1186","volume":"20","author":[{"given":"Yiyu","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaxin","family":"LI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2873-1804","authenticated-orcid":false,"given":"Daozhang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shusheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,3]]},"reference":[{"issue":"4","key":"704_CR1","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.ucl.2009.07.003","volume":"36","author":"W Bushman","year":"2009","unstructured":"Bushman W. Etiology, epidemiology, and natural history. Urol Clin N Am. 2009;36(4):403\u201315.","journal-title":"Urol Clin N Am"},{"issue":"3","key":"704_CR2","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1097\/01.ju.0000153518.11501.d2","volume":"173","author":"AD Rule","year":"2005","unstructured":"Rule AD, Lieber MM, Jacobsen SJ, et al. Is benign prostatic hyperplasia a risk facto r for chronic renal failure? J Urol. 2005;173(3):691\u20136.","journal-title":"J Urol"},{"issue":"3","key":"704_CR3","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.urology.2014.05.028","volume":"84","author":"B Peyronnet","year":"2014","unstructured":"Peyronnet B, Pradere B, Brichart N, et al. Complications associated with Photoselective vaporization of the prostate: categorization by a panel of GreenLight users according to Clavien score and report of a single-center experience. Urology. 2014;84(3):657\u201364.","journal-title":"Urology"},{"issue":"1","key":"704_CR4","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.eururo.2013.03.004","volume":"64","author":"M Oelke","year":"2013","unstructured":"Oelke M, Bachmann A, Descazeaud A, et al. EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol. 2013;64(1):118\u201340.","journal-title":"Eur Urol"},{"key":"704_CR5","doi-asserted-by":"crossref","unstructured":"Mamoulakis C, de la Rosette, Jean J.M.C.H (2015) Bipolar transurethral resection of the prostate: Darwinian evolution of an instrumental technique. Urology 85(5):1143\u20131150.","DOI":"10.1016\/j.urology.2015.01.003"},{"key":"704_CR6","unstructured":"Mebust WK (2003) Transurethral surgery. ln: Walsh PC, Retok AB, Vaughan ED, Wein AJ (eds) Campbell\u2019 s urology, Vol 2.8th (ed) Philadelphia: Saunders, pp 1479\u20131505."},{"issue":"3","key":"704_CR7","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1089\/end.2014.0207","volume":"29","author":"W Huang","year":"2015","unstructured":"Huang W, Guo Y, Xiao G, et al. Treatment of benign prostatic hyperplasia using transurethral Split of the prostate with a columnar balloon catheter. J Endourol. 2015;29(3):344\u201350.","journal-title":"J Endourol"},{"issue":"40","key":"704_CR8","doi-asserted-by":"publisher","first-page":"e4657","DOI":"10.1097\/MD.0000000000004657","volume":"95","author":"W Huang","year":"2016","unstructured":"Huang W, Huang Z, Xiao G, et al. Effect of transurethral split of the prostate using a double-columnar balloon catheter for benign prostatic hyperplasia. Medicine. 2016;95(40):e4657.","journal-title":"Medicine"},{"key":"704_CR9","unstructured":"Higgins JPT, Green S (2011) Cochrane handbook for systematic reviews of interventions, version 5.1.0. The Cochrane collaboration. www.cochrane-handbook.org."},{"key":"704_CR10","doi-asserted-by":"crossref","unstructured":"Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009:339.","DOI":"10.1136\/bmj.b2535"},{"issue":"3","key":"704_CR11","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177\u201388.","journal-title":"Control Clin Trials"},{"issue":"29","key":"704_CR12","first-page":"55","volume":"23","author":"KONG Min","year":"2017","unstructured":"Min KONG, Jun CHEN, Wu-zhen YUAN, et al. Efficacy of modified transurethral split of prostate enlargement for the treatment of benign prostatic hyperplasia. Contemp Med. 2017;23(29):55\u20136.","journal-title":"Contemp Med"},{"issue":"06","key":"704_CR13","first-page":"423","volume":"16","author":"WANG Qi","year":"2017","unstructured":"Qi WANG, Chaokun LI, Liang HUANG. Efficacy of transurethral columnar balloon dilation of prostate in treatment of benign prostatic hyperplasia in high risk elderly patients. Chin J Multip Organ Dis Elderly. 2017;16(06):423\u20137.","journal-title":"Chin J Multip Organ Dis Elderly"},{"issue":"05","key":"704_CR14","first-page":"930","volume":"23","author":"Z Jin","year":"2018","unstructured":"Jin Z. Analysis of the application effect of transurethral split of prostate enlargement in patients with benign prostatic hyperplasia. Zhejiang J Traumatic Surg. 2018;23(05):930\u20131.","journal-title":"Zhejiang J Traumatic Surg"},{"issue":"2","key":"704_CR15","first-page":"361","volume":"35","author":"Q Kong","year":"2018","unstructured":"Kong Q, Jingwei S, Bin L, et al. Effect of transurethral split of the prostate for the treatment of prostatic hyperplasia in the elderly. Chin J Exp Surg. 2018;35(2):361\u20132.","journal-title":"Chin J Exp Surg"},{"issue":"05","key":"704_CR16","first-page":"904","volume":"23","author":"L Hong","year":"2018","unstructured":"Hong L. Cylindrical water balloon prostate expansion catheter for the treatment of benign prostatic hyperplasia. Zhejiang J Traumatic Surg. 2018;23(05):904\u20135.","journal-title":"Zhejiang J Traumatic Surg"},{"key":"704_CR17","first-page":"326","volume":"48","author":"L Shuzhi","year":"2018","unstructured":"Shuzhi L, Jingren Z, Bao Z, et al. Clinical study of columnar water sac in the treatment of benign prostatic hyperplasia with neurogenic bladder. Health Guide. 2018;48:326.","journal-title":"Health Guide"},{"issue":"10","key":"704_CR18","first-page":"83","volume":"4","author":"B Wang","year":"2019","unstructured":"Wang B. Clinical effect of transurethral split of prostate in the treatment of benign prostatic hyperplasia. Clin Res Pract. 2019;4(10):83\u20135.","journal-title":"Clin Res Pract"},{"issue":"3","key":"704_CR19","first-page":"140","volume":"17","author":"G Sivarajan","year":"2015","unstructured":"Sivarajan G, Borofsky MS, Shah O, et al. The role of minimally invasive surgical techniques in the Management of Large-gland Benign Prostatic Hypertrophy. Rev Urol. 2015;17(3):140\u20139.","journal-title":"Rev Urol"},{"issue":"8","key":"704_CR20","doi-asserted-by":"publisher","first-page":"412","DOI":"10.4140\/TCP.n.2016.412","volume":"31","author":"TJ Woodard","year":"2016","unstructured":"Woodard TJ, Manigault KR, Mcburrows NN, et al. Management of Benign Prostatic Hyperplasia in older adults. Consult Pharm. 2016;31(8):412\u201324.","journal-title":"Consult Pharm"},{"issue":"1S1","key":"704_CR21","first-page":"10","volume":"23","author":"U Blankstein","year":"2016","unstructured":"Blankstein U, Van AB, Elterman DS. BPH update: medical versus interventional management. Canadian. J Urol. 2016;23(1S1):10.","journal-title":"J Urol"},{"issue":"1","key":"704_CR22","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.juro.2008.03.058","volume":"180","author":"O Reich","year":"2008","unstructured":"Reich O, Gratzke C, Bachmann A, et al. Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients. J Urol. 2008;180(1):246\u20139.","journal-title":"J Urol"},{"issue":"3","key":"704_CR23","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1148\/radiology.152.3.6205416","volume":"152","author":"HJ Burhenne","year":"1984","unstructured":"Burhenne HJ, Chisholm RJ, Quenville NF. Prostatic hyperplasia: radiological intervention. Work in progress. Radiology. 1984;152(3):655\u20137.","journal-title":"Radiology"},{"key":"704_CR24","first-page":"426","volume":"147","author":"F Castaneda","year":"1987","unstructured":"Castaneda F, Letourneau JG, Reddy P, et al. Alternative treatment of prostatic urethral obstruction secondary to benign prostatic hypertrophy. Non-surg Ball Catheter Prost Dilatation RoFo. 1987;147:426\u20139.","journal-title":"Non-surg Ball Catheter Prost Dilatation RoFo"},{"issue":"2","key":"704_CR25","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1148\/radiology.177.2.1699247","volume":"177","author":"NF Wasserman","year":"1990","unstructured":"Wasserman NF, Reddy PK, Zhang G, et al. Experimental treatment of benign prostatic hyperplasia with transurethral balloon dilation of the prostate: preliminary study in 73 humans. Radiology. 1990;177(2):485\u201394.","journal-title":"Radiology"},{"key":"704_CR26","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/j.1464-410X.1989.tb05321.x","volume":"64","author":"KP Gill","year":"1989","unstructured":"Gill KP, Machan LS, Allison DJ, et al. Bladder outflow tract obstruction from benign prostatic hypertrophy treated by balloon dilatation. Br J Urol. 1989;64:618\u201322.","journal-title":"Br J Urol"},{"issue":"2","key":"704_CR27","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1464-410X.1991.tb15104.x","volume":"67","author":"J Mcloughlin","year":"1991","unstructured":"Mcloughlin J, Keane PF, Jager R, et al. Dilatation of the prostatic urethra with 35 mm balloon. BJU Int. 1991;67(2):177\u201381.","journal-title":"BJU Int"},{"issue":"3","key":"704_CR28","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/S0022-5347(17)37331-7","volume":"147","author":"H Lepor","year":"1992","unstructured":"Lepor H, Sypherd D, Machi G, et al. Randomized double blind study comparing the effectiveness of balloon dilation of the prostate and cystoscopy for the treatment of symptomatic benign prostatic hyperplasia. J Urol. 1992;147(3):639\u201342.","journal-title":"J Urol"},{"issue":"2","key":"704_CR29","first-page":"83","volume":"86","author":"JA Vale","year":"1993","unstructured":"Vale JA. Balloon dilation of the prostate-should it have a place in the urologist's armamentarium? J R Soc Med. 1993;86(2):83\u20136.","journal-title":"J R Soc Med"},{"issue":"03","key":"704_CR30","first-page":"198","volume":"13","author":"B Weizhen","year":"2019","unstructured":"Weizhen B, Wang X, Wang D, et al. The application of endoscopic assisted direct vision in transurethral columnar balloon dilation of the prostate. Chin J Endourol. 2019;13(03):198\u2013202.","journal-title":"Chin J Endourol"},{"issue":"04","key":"704_CR31","first-page":"263","volume":"7","author":"C Wang","year":"2018","unstructured":"Wang C, Xiaolin M, Wenfeng L, et al. Transurethral columnar balloon dilation of prostate under ultrasound guidance for treatment of benign prostatic hyperplasia. J Minim Invasive Urol. 2018;7(04):263\u20136.","journal-title":"J Minim Invasive Urol"},{"issue":"9","key":"704_CR32","doi-asserted-by":"publisher","first-page":"e12501","DOI":"10.1371\/journal.pone.0012501","volume":"5","author":"BF Daniella","year":"2010","unstructured":"Daniella BF, Funda VL, Coleman IM, et al. The effects of aging on the molecular and cellular composition of the prostate microenvironment. PLoS One. 2010;5(9):e12501.","journal-title":"PLoS One"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-020-00704-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12894-020-00704-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-020-00704-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T08:39:34Z","timestamp":1630658374000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcurol.biomedcentral.com\/articles\/10.1186\/s12894-020-00704-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,3]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["704"],"URL":"https:\/\/doi.org\/10.1186\/s12894-020-00704-4","relation":{},"ISSN":["1471-2490"],"issn-type":[{"type":"electronic","value":"1471-2490"}],"subject":[],"published":{"date-parts":[[2020,9,3]]},"assertion":[{"value":"15 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All analyses were based on previous published studies, thus no ethical approval and patient consent are required.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"141"}}